Table 2.
Left ventricular assist deviceb | Fenestrated endovascular aneurysm repairb | Expensive cancer drugs | Eylea and Lucentis | Population screening for colon cancer | Robotic surgery | |
---|---|---|---|---|---|---|
Medical doctors | 5 | 8 | 12 | 8 | 8 | 6 |
Managers/directors | 2 | 3 | 1 | 1 | 2 | 2 |
Professional scientific associations | 1 | 1 | 1 | 1 | ||
Patient associations | 1 | 1 | 1 | 1 | ||
Manager sales | 1 | 3 | 1 | 1 | ||
Board of directors | 1 | 1 | 5 | 4 | 4 | 2 |
Insurer | 1 | 1 | 1 | 1 | 2 | |
Hospital pharmacists | 3 | |||||
Other | 1 | 1 | ||||
Hospital respondents recruited from: | Recruited from three university medical centres | Recruited from two general hospitals, four university medical centres | Recruited from four general hospitals, five university medical centers | Recruited from two general hospitals, two specialized clinics, four university medical centers | Recruited from six general hospitals, four university medical centers | Recruited from six general hospitals, three university medical centers |
a Informants may be listed on several roles or columns. For example, a medical doctor may be a part-time member of the sales team of the hospital, or a member of the board of directors may have spoken about two or more case studies
b We interviewed active members of the professional scientific associations (f.e. members of guideline committees), but not formally as representatives of the professional scientific association